Comparing GeneNews (OTCMKTS:GNWSF) & Riot Blockchain (RIOT)
Riot Blockchain (NASDAQ:RIOT) and GeneNews (OTCMKTS:GNWSF) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.
This table compares Riot Blockchain and GeneNews’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility and Risk
Riot Blockchain has a beta of 2.35, suggesting that its share price is 135% more volatile than the S&P 500. Comparatively, GeneNews has a beta of 4.63, suggesting that its share price is 363% more volatile than the S&P 500.
This is a breakdown of recent ratings and target prices for Riot Blockchain and GeneNews, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Riot Blockchain currently has a consensus price target of $4.00, indicating a potential upside of 117.39%. Given Riot Blockchain’s higher possible upside, analysts clearly believe Riot Blockchain is more favorable than GeneNews.
Valuation & Earnings
This table compares Riot Blockchain and GeneNews’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Riot Blockchain||$170,000.00||157.15||-$19.84 million||($2.71)||-0.68|
GeneNews has higher revenue and earnings than Riot Blockchain.
Insider & Institutional Ownership
8.7% of Riot Blockchain shares are held by institutional investors. 2.7% of Riot Blockchain shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Riot Blockchain beats GeneNews on 7 of the 11 factors compared between the two stocks.
Riot Blockchain Company Profile
Riot Blockchain, Inc. focuses on building, supporting, and operating blockchain technologies, primarily through its cryptocurrency mining operations and other developed businesses, as well as joint ventures, acquisitions, and targeted investments in the sector. Its primary focus is on Bitcoin and general blockchain technology. The company leverages its expertise and network to build and support blockchain technology companies. It builds a cryptocurrency mining operation and operates specialized computers that generate cryptocurrency, primarily Bitcoin. The company also holds interests in various activities, including purchasing and selling cryptocurrencies; providing accounting, audit, and verification services for blockchain based assets, such as cryptocurrencies; and developing TessPay, a payments ecosystem for component and sub-component supply chain settlements, and other blockchain solutions for telecommunications companies. As of March 31, 2018, approximately 3,500 of the miners were installed and operating. The company was formerly known as Bioptix, Inc. and changed its name to Riot Blockchain, Inc. in October 2017. Riot Blockchain, Inc. was founded in 2000 and is based in Castle Rock, Colorado.
GeneNews Company Profile
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company’s lead product is ColonSentry, a blood test to determine an individual’s current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is based in Richmond Hill, Canada.
Receive News & Ratings for Riot Blockchain Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Riot Blockchain and related companies with MarketBeat.com’s FREE daily email newsletter.